2021. Efficacy of Bevacizumab to Reduce Lid Margin Vascularity and Alteration in Tear Film Status. Annals of King Edward Medical University. 27, Special Issue (Jul-Sep) (Nov. 2021), 368–371. DOI:https://doi.org/10.21649/akemu.v27iSpecial Issue (Jul-Sep).4656.